Fundz

Harrow Health, Inc. reported raising $10.7 Million in an initial SEC Form D filing, from an offering of $10.7 Million

PUBLIC · HROWMay 14, 2021

Amount Raised

$10.7 Million

$10.7 Million sold, per SEC Form D (first sale May 14, 2021)

Round Type

Venture

NashvilleBiotechnologyHealthcareHealth CarePharmaceutical

Quick answer

Harrow raised $10.7 Million in a funding round, dated May 14, 2021. Harrow is based in Nashville, Tennessee, United States.

How much did Harrow raise?
Harrow raised $10.7 Million in a funding round on May 14, 2021.
What does Harrow do?
Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market, dedicated to innovation and providing affordable, accessible medications.
Where is Harrow based and how big is it?
Harrow is based in Nashville, Tennessee, United States. Fundz records about 282 employees.
Who are the decision-makers at Harrow?
Fundz holds 2 contacts at Harrow, including the Senior Vice President and GM Manufacturing Operations. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Pharmaceutical around the same time

Companies in the same sectors as Harrow that raised within 45 days of this round, from Fundz verified event records.

  • Arbutus raised $81M on June 23, 2021.
  • Zevra Therapeutics, Inc. raised $39M on June 22, 2021.
  • Nuvalent raised $135M on May 12, 2021.
  • Nuvalent raised $135M (Series B) on May 11, 2021.
  • Os Therapies raised $6M (Series A) on April 20, 2021.
  • Vivani Medical, Inc. raised $28M on April 7, 2021.

Who to call at Harrow, and when

A new round usually means Harrow is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Harrow raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Harrow, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Harrow. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Harrow

Location

Nashville, Tennessee, United States

About

Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market, dedicated to innovation and providing affordable, accessible medications. By closely listening to the needs of providers and patients, the company delivers high-quality products and services. Harrow’s commitment to excellence has made it one of the fastest-growing ophthalmic pharmaceutical companies in the United States.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Harrow raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsSanjay S., Senior Vice President and GM Manufactur… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Harrow's next move

See what Strategic adds

Harrow raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.